McCann launches experiential marketing shop

Share this article:
McCann Worldgroup is launching a health and wellness experiential marketing practice under the umbrella of its Momentum network.

The agency, Momentum Wellness, will be jointly managed by McCann Healthcare and Momentum Worldwide, which handles events and promotions, sponsorships, retail and point of sale marketing for big blue chip brands like Verizon, Coca-Cola, Budweiser and American Express.

The shop, based in New York, will focus on experiential marketing and strategic partnerships for both professional and consumer audiences. Founding clients include Cleveland Clinic, Quaker Oats, the American Diabetes Association, the Multiple Myeloma Research Foundation and Reader's Digest.

It will be led by president John Hopper, former CEO of Power Marketing Partners and managing partner of several WPP agencies, and global wellness director Michael Semler of Momentum Worldwide's healthcare practice.

McCann Healthcare clients include GlaxoSmithKline, Johnson & Johnson, Pfizer, Nestle, Novartis and USAID.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...